scholarly article | Q13442814 |
P2093 | author name string | B. C. Kim | |
J-S Lee | |||
Y-N Kim | |||
Y-S Lee | |||
J-J Lee | |||
B. L. Lee | |||
M-J Park | |||
P2860 | cites work | Biochimica et Biophysica Acta | Q864239 |
Oncogene-Induced Senescence: Putting the Brakes on Tumor Development | Q22065360 | ||
A biomarker that identifies senescent human cells in culture and in aging skin in vivo | Q24562644 | ||
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis | Q24681977 | ||
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas | Q29616243 | ||
Restoration of p53 function leads to tumour regression in vivo | Q29618727 | ||
Absence of AKT1 mutations in glioblastoma | Q30439629 | ||
p53 suppresses structural chromosome instability after mitotic arrest in human cells | Q33766312 | ||
Induction of cell death by radiotherapy | Q33872968 | ||
Senescence as an anticancer mechanism | Q34579345 | ||
Targeted molecular therapy of GBM. | Q35064179 | ||
Tumor cell senescence in cancer treatment | Q35143435 | ||
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme | Q35382829 | ||
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation | Q35928960 | ||
Cellular senescence and cancer treatment. | Q36616891 | ||
Senescence in tumours: evidence from mice and humans | Q36903843 | ||
Stress-induced premature senescence (SIPS)--influence of SIPS on radiotherapy | Q37064796 | ||
The role of PTEN signaling perturbations in cancer and in targeted therapy | Q37270446 | ||
Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway | Q39316242 | ||
A NADPH oxidase-dependent redox signaling pathway mediates the selective radiosensitization effect of parthenolide in prostate cancer cells | Q39726912 | ||
Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species | Q39783612 | ||
Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence | Q39844229 | ||
Cathepsin D protects human neuroblastoma cells from doxorubicin-induced cell death | Q39970539 | ||
Protein phosphatase activity of PTEN inhibited the invasion of glioma cells with epidermal growth factor receptor mutation type III expression. | Q40403730 | ||
Radiation-induced apoptosis: Relevance to radiotherapy | Q40433820 | ||
Dinstinct ROS and biochemical profiles in cells undergoing DNA damage-induced senescence and apoptosis | Q40438677 | ||
Apoptosis induced by high- and low-LET radiations | Q40440458 | ||
Cytostatic effect of TNFalpha on cancer cells is independent of p21WAF1. | Q41085041 | ||
ROS production by adrenodoxin does not cause apoptosis in fission yeast | Q42519169 | ||
Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis | Q42601114 | ||
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells | Q43513023 | ||
Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes | Q43739533 | ||
Genetic pathways to glioblastoma: a population-based study | Q44673208 | ||
p53 disruption profoundly alters the response of human glioblastoma cells to DNA topoisomerase I inhibition | Q44762886 | ||
Akt-induced cellular senescence: implication for human disease | Q47990548 | ||
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
Identification of molecular subtypes of glioblastoma by gene expression profiling | Q48332534 | ||
Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints. | Q51755718 | ||
Programmed cell death in whole body and organ systems by low dose radiation | Q68021085 | ||
Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis | Q73596247 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cellular senescence | Q9075999 |
apoptotic process | Q14599311 | ||
P304 | page(s) | 666-677 | |
P577 | publication date | 2010-11-12 | |
P1433 | published in | Cell Death & Differentiation | Q2943974 |
P1476 | title | PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation | |
P478 | volume | 18 |
Q52631151 | A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens. |
Q34099246 | A novel human TPIP splice-variant (TPIP-C2) mRNA, expressed in human and mouse tissues, strongly inhibits cell growth in HeLa cells |
Q90641009 | AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells |
Q38402718 | Acyl-CoA thioesterase 7 is involved in cell cycle progression via regulation of PKCζ-p53-p21 signaling pathway. |
Q34991231 | Aging-related gene signature regulated by Nlrp3 predicts glioma progression |
Q35871493 | Apoptosis and the target genes of microRNA-21. |
Q47136308 | Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications |
Q58804966 | Autophagic flux response and glioblastoma sensitivity to radiation |
Q36214533 | Autophagy and lysosomal related protein expression patterns in human glioblastoma |
Q42259684 | Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells |
Q39365401 | Cell Cycle Control by PTEN. |
Q39400607 | Cell cycle arrest and apoptosis by expression of a novel TPIP (TPIP-C2) cDNA encoding a C2-domain in HEK-293 cells |
Q37915652 | Cellular Senescence - its role in cancer and the response to ionizing radiation |
Q64272067 | Cellular senescence: a promising strategy for cancer therapy |
Q52560717 | Co-sequencing and novel delayed anti-correlation identify function for pancreatic enriched microRNA biomarkers in a rat model of acute pancreatic injury. |
Q37607921 | Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line |
Q48197073 | Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells |
Q35048848 | Coordination between p21 and DDB2 in the cellular response to UV radiation |
Q38743679 | Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells |
Q36916729 | Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways |
Q34286305 | Differences in molecular genetics between pediatric and adult malignant astrocytomas: age matters. |
Q36733968 | Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis |
Q39355459 | Effects of 837 and 1950 MHz radiofrequency radiation exposure alone or combined on oxidative stress in MCF10A cells |
Q91542984 | Epigallocatechin-3-gallate induces telomere shortening and clastogenic damage in glioblastoma cells |
Q34180117 | Exploiting tumor cell senescence in anticancer therapy |
Q35760625 | Genomic aberrations in pediatric diffuse intrinsic pontine gliomas |
Q38727372 | Glioblastoma Therapy Can Be Augmented by Targeting IDH1-Mediated NADPH Biosynthesis |
Q39214706 | HDAC inhibitor DWP0016 activates p53 transcription and acetylation to inhibit cell growth in U251 glioblastoma cells |
Q37353998 | Heparan sulfation is essential for the prevention of cellular senescence |
Q61446856 | Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells |
Q42427997 | Hsp90 Inhibitors NVP-AUY922 and NVP-BEP800 May Exert a Significant Radiosensitization on Tumor Cells along with a Cell Type-Specific Cytotoxicity |
Q39236998 | Identification of NCF2/p67phox as a novel p53 target gene |
Q90344354 | Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy |
Q37126130 | Inhibition of polo-like kinase 1 in glioblastoma multiforme induces mitotic catastrophe and enhances radiosensitisation |
Q88768081 | Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues |
Q38051761 | Interleukins in glioblastoma pathophysiology: implications for therapy. |
Q55327757 | Investigating the role of Hedgehog/GLI1 signaling in glioblastoma cell response to temozolomide. |
Q35998585 | Lamin B1 loss is a senescence-associated biomarker. |
Q90427860 | MDM4 contributes to the increased risk of glioma susceptibility in Han Chinese population |
Q37696978 | MEK1 is required for the development of NRAS-driven leukemia |
Q92629967 | Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells |
Q35910713 | MiR-106b induces cell radioresistance via the PTEN/PI3K/AKT pathways and p21 in colorectal cancer |
Q35974749 | MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN. |
Q38070437 | Molecular diagnostics in paediatric glial tumours |
Q38061832 | NRF2 and p53: Januses in cancer? |
Q98184315 | Oncogenic Smurf1 promotes PTEN wild-type glioblastoma growth by mediating PTEN ubiquitylation |
Q35234429 | Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation |
Q41818544 | PRMT5-PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells |
Q49550289 | PTEN Inhibition in Human Disease Therapy |
Q52661710 | PTEN at the interface of immune tolerance and tumor suppression. |
Q88956977 | Paraquat and Maneb Exposure Alters Rat Neural Stem Cell Proliferation by Inducing Oxidative Stress: New Insights on Pesticide-Induced Neurodevelopmental Toxicity |
Q62512396 | Polyethylenimine–Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells |
Q47339124 | RELN signaling modulates glioblastoma growth and substrate-dependent migration. |
Q93049221 | Radiosensitization and a Less Aggressive Phenotype of Human Malignant Glioma Cells Expressing Isocitrate Dehydrogenase 1 (IDH1) Mutant Protein: Dissecting the Mechanisms |
Q50853512 | Reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress. |
Q31118089 | Restoration of sensitivity in chemo-resistant glioma cells by cold atmospheric plasma |
Q38082328 | Senescence and aging: the critical roles of p53. |
Q34619554 | Senescence and apoptosis: dueling or complementary cell fates? |
Q37219543 | Senescence associated secretory phenotype profile from primary lung mice fibroblasts depends on the senescence induction stimuli |
Q35273402 | Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe |
Q33753441 | Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways. |
Q89835065 | The Histone Code of Senescence |
Q26764947 | Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve |
Q38845930 | Treatment of adult and pediatric high-grade gliomas with Withaferin A: antitumor mechanisms and future perspectives. |
Q38941587 | UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop. |
Q24301358 | Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment |
Q58600725 | mTOR kinase leads to PTEN-loss-induced cellular senescence by phosphorylating p53 |
Q38755629 | miR-214 promotes radioresistance in human ovarian cancer cells by targeting PETN. |
Q55002919 | p53 and metabolism: from mechanism to therapeutics. |
Q36581663 | p63 the guardian of human reproduction |
Search more.